Plato Gold Corp (PGC) Fair Value & Analysis
Healthcare · CA · Market cap A$273M
Fair value as of: Jun 26, 2026
From 15 valuation models · updated 3 days ago
Share price −13.3% over the past month.
Price vs Fair Value (12 months)
12‑month range A$0.1300 – A$0.4000 · fair‑value band A$0.2100 – A$0.3400 · the A$0.1300 price screens below the A$0.2700 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Plato Gold Corp (PGC) currently trades at A$0.1300, while our model-based Fair Value estimate is A$0.2700 — implying the stock looks roughly 107.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Plato Gold Corp generated revenue of A$3.7B at a net margin of -0.4%. Revenue grew 2.9% year over year. It earns a return on equity of -4.5%. Net debt stands at A$275M. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
Plato Gold Corp., an exploration company, engages in the exploration and development of mineral properties in Canada. It explores gold, platinum, niobium, and rare mineral properties. The company's principal projects include the Good Hope Niobium Project, which comprises 296 claims covering approximately 6,035 hectares in Killala Lake Area and Cairngorm Lake Area Townships, northwest of Marathon, Ontario; the Pic River Platinum Group Metals Project, consisting of 111 single cell mining claims over approximately 2,352 hectares in Foxtrap Lake and Grain Township, Thunder Bay Mining District, Ontario; Lolita Project in Santa Cruz, Argentina, which includes contiguous mineral rights totaling 9,672 hectares; and Timmins Gold Project in Northern Ontario. The company is based in Toronto, Canada.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Plato Gold Corp reported revenue of A$3.6B in FY2025 versus A$236M in FY2021, a compound +97.9%/yr. Reported net income was A$20.6M in FY2025, compounding +25.6%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Medical Distribution stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| McKesson Corporation M1CK34 | R$958.36 | R$188.90 | -80% |
| Cencora, Inc C1CO34 | R$709.32 | R$400.31 | -44% |
| Cardinal Health, Inc CAH | $222.74 | $141.77 | -36% |
| Sigma Healthcare Limited SIGGF | $2.35 | $0.6300 | -73% |
| Sitka Gold Corp SIG | A$2.92 | A$1.20 | -59% |
| Shanghai Pharmaceuticals Holding 601607 | ¥15.96 | ¥45.15 | +183% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Plato Gold Corp (PGC) undervalued?
What is the fair value of PGC?
What is the quality score of PGC?
What is the revenue of Plato Gold Corp (PGC)?
What is the net profit margin of PGC?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.